Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Support us
Support us
  • Home
  • Aimée du Chatinier

Aimée du Chatinier

PhD student

Identification of epigenetic drugs as radiosensitizers and escape mechanisms in pediatric high-grade gliomas

Phone 088 97 25 214
Email A.duChatinier@prinsesmaximacentrum.nl

Publications

7 publications in total

  • Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors

    • sep. 2024
    • Dennis S, Metselaar, et al
    • Cell Reports Medicine

  • Microglia in pediatric brain tumors

    • nov. 2023
    • Aimée, du Chatinier, et al
    • Cell Reports Medicine

  • Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma

    • jun. 2022
    • Aimée, Du Chatinier, et al
    • Neurooncology Advances

  • AURKA and PLK1 inhibition selectively and synergistically block cell cycle progression in diffuse midline glioma

    • jun. 2022
    • Dennis S., Metselaar, et al
    • iScience

  • Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments

    • apr. 2021
    • Dennis S., Metselaar, et al
    • Frontiers in Oncology
View all publications